CytoSorb in the management of severe septic shock after coronary artery bypass graft surgery
Achieving sufficient adsorption of increased immune mediators with the help of hemadsorption has been a breakthrough discovery in the field of cardiac sciences. Any surgery, injury, or trauma causes the release of pro-inflammatory mediators, which may trigger a severe systemic inflammatory response...
Main Authors: | Amit Prakash, Vishal Garg, Dinesh Kumar Mittal, Anurag Bhushan Upadhyay |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Heart India |
Subjects: | |
Online Access: | http://www.heartindia.net/article.asp?issn=2321-449x;year=2020;volume=8;issue=3;spage=151;epage=153;aulast=Prakash |
Similar Items
-
Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
by: Christopher Rugg, et al.
Published: (2020-11-01) -
To Hemoadsorb or Not to Hemoadsorb—Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock
by: Carmen Orban, et al.
Published: (2025-01-01) -
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
by: Aron Jansen, et al.
Published: (2023-03-01) -
Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Marianne Alarie, et al.
Published: (2022-07-01) -
CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
by: Anouk Frering, MD, et al.
Published: (2025-02-01)